Someone gets COVID, recovers from the acute illness, and then just never bounces back. I hear this constantly. Months go by. Sometimes years. Fatigue that doesn't lift, brain fog, chest tightness, a heart rate that spikes from walking up a flight of stairs. That's Long COVID for a huge number of people, and it's still catching a lot of doctors off guard.
Part of the problem is that Long COVID doesn't look like one illness. It looks like twenty. Different patients get different combinations of symptoms, which makes it hard to treat with a single protocol, or honestly, to even get taken seriously in the first place. I've talked to people who spent a year bouncing between specialists before anyone connected the dots back to their original infection.
"We're seeing patients who were healthy and active before their infection, and now they can't get through a workday without crashing," says Dr. Inbar Almon Tofan, Medical Doctor and Medical Supervisor at Apheresis Center. "The challenge is that Long COVID affects multiple body systems at once, so treatment has to be just as multidimensional."
What's Actually Happening in the Body?
Researchers have zeroed in on a few mechanisms that keep showing up in Long COVID patients. Micro-clotting is one of the bigger ones. Tiny blood clots, sometimes called microclots, can form in small blood vessels and interfere with how oxygen gets delivered to tissue. That alone explains a lot of the fatigue and exercise intolerance patients describe. Someone who used to run five miles without thinking twice now gets winded walking to their car.
Inflammation is another piece of it. Some patients show ongoing immune activation months after the initial infection, like their body's still fighting something it can't fully shake. On top of that, blood tends to run thicker in a lot of these patients, which just compounds the circulation problems the microclots are already causing.
None of this shows up on a standard blood panel. And that's exactly why so many Long COVID patients get told their labs look fine. The tests that would actually catch this aren't the ones most doctors think to run.
Why Long COVID Is So Hard to Treat?
Fatigue in Long COVID isn't the kind of tired that a good night's sleep fixes. Patients describe post-exertional malaise, where doing too much one day triggers a crash a day or two later, almost like their body sends a delayed invoice. Add in brain fog, shortness of breath, heart palpitations, and joint pain, and you've got a condition touching the cardiovascular system, the nervous system, and the immune system all at once.
Standard treatment tends to focus on individual symptoms. Something for the fatigue, something else for the palpitations, another thing for the brain fog. That can help around the edges. But it doesn't touch what's actually driving the symptoms underneath, and patients often know it. They can feel that they're managing pieces instead of fixing the actual problem.
How H.E.L.P. Apheresis Fits Into Treatment?
This is where blood-filtering treatments have started getting real attention. H.E.L.P. apheresis, short for Heparin-induced Extracorporeal LDL Precipitation, was originally developed for cardiovascular conditions. It works by filtering blood outside the body, removing excess LDL cholesterol, fibrinogen, and other substances tied to clotting and inflammation.
For Long COVID patients specifically, that filtering process targets exactly the mechanisms researchers keep pointing to. Reducing fibrinogen and other clotting factors can ease the microclotting that's restricting blood flow. Improving blood viscosity can make circulation more efficient. And clearing out some of the inflammatory markers circulating in the blood may help calm the ongoing immune activation a lot of these patients are dealing with.
I've heard clinicians describe it as giving the blood a chance to move the way it's supposed to again, which sounds simple, but for patients who've been stuck for years, that shift can be the first real change they notice. Apheresis Center offers this Long Covid Treatment through its H.E.L.P. apheresis program, built specifically around patients dealing with circulation and clotting issues tied to Long COVID and related conditions.
Who Tends to Benefit Most?
This isn't a first-line treatment for everyone with Long COVID, and it shouldn't be presented that way. Patients tend to be considered for it after standard approaches haven't moved the needle, especially when testing points to elevated fibrinogen, abnormal blood viscosity, or other markers connected to microclotting.
A full evaluation usually comes first. Bloodwork, symptom history, and a real look at what's driving that particular patient's presentation, not just their diagnosis on paper. Long COVID isn't one condition wearing different masks. It's genuinely different for each person, which means the workup has to be just as thorough as the treatment itself.
"Every Long COVID patient we see has a slightly different clinical picture," Dr. Almon Tofan says. "That's why a comprehensive evaluation has to come before any treatment recommendation. We're not treating a diagnosis. We're treating what's actually happening in that person's body."
Where This Leaves Patients?
Long COVID research is still moving fast, and treatment options are expanding as scientists get a clearer picture of what's actually driving the illness. For patients who've spent months or years being told their labs look normal, that shift matters more than it might sound like on paper. It means there's finally something concrete to test for, and something concrete to treat.
Recovery isn't instant, and it doesn't look the same for everyone. But for patients who've felt stuck for years, watching their labs come back clean while their body tells a completely different story, having a treatment that targets the actual mechanism behind their symptoms, instead of just managing them one at a time, can be the first real progress they've seen since getting sick.
